Baird Raises Ventas Price Target to $65 From $60
J.P. Morgan Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $71
JPMorgan Adjusts Price Target on Ventas to $71 From $67, Keeps Neutral Rating
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $79
Wedbush Adjusts Ventas Price Target to $75 From $71, Maintains Outperform Rating
Evercore Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $72
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $70
Raymond James Adjusts Price Target on Ventas to $70 From $68
Morgan Stanley Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $65
Morgan Stanley Sticks to Their Hold Rating for Ventas (VTR)
Morgan Stanley Raises Price Target on Ventas to $65 From $57, Keeps Equalweight Rating
Ventas Is Maintained at Sector Perform by Scotiabank
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $65
BMO Capital Adjusts Ventas Price Target to $72 From $70
Ventas Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Ventas Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Ventas Inc(VTR.US) to Buy Rating, Raises Target Price to $71
Ventas (VTR) Was Upgraded to a Buy Rating at Wells Fargo
Mizuho Securities Initiates Ventas Inc(VTR.US) With Buy Rating, Announces Target Price $71